期刊文献+

尿路感染病原菌分布及耐药分析 被引量:3

Distribution and drug resistance analysis of pathogenic bacteria of urinary tract infection
下载PDF
导出
摘要 目的研究福州地区尿路感染病原菌的分布及耐药情况。方法2013年1~12月,共收集2958株尿路感染病原菌进行鉴定和药敏试验。结果2958株病原菌中前4位依次是大肠埃希菌、真菌、粪肠球菌和肺炎克雷伯菌。大肠埃希菌耐药率最高的抗生素是氨苄西林,而对氨苄西林/舒巴坦复合剂的耐药率明显低于对前者的耐药率(P〈0.05);对阿米卡星的耐药率也明显低于庆大霉素(P〈0.05)。结论大肠埃希菌仍是尿路感染的主要病原菌,应根据细菌的药敏试验结果使用抗生素。 Objective To study distribution of drug resistance pathogenic bacteria of urinary tract infection in Fuzhou. Methods 2958 strains of pathogenic bacteria of urinary tract infection were collected and identified and given drug sensitive test from January to December 2013. Results Among 2958 strains of pathogenic bacteria,the top 4 were Es- cherichia eoli,fungi,Enteroeoccus faecalis and Klebsiella pnenmoniae Respectively.Antibiotics having the highest rate of drug resistance to Escherichia coli was ampicillin,the dnlg resistance rate to ampicillin/sulbactam compound was obvi- ously than that of ampicillin (P〈0.05);the drug resistance rate to amikacin was obviously than that of gentamicin (P〈 0.05). Conclusion Eseherichia coli is main pathogenic bacteria of urinary tract infection and the use of antibiotics should be based on the results of drug sensitive test of bacteria.
出处 《中国当代医药》 2014年第7期91-93,共3页 China Modern Medicine
基金 福建省卫生厅青年基金(2013-2-39)
关键词 尿路感染 病原菌 耐药性 Urinary tract infection Pathogenic bacteria Drug resistance
  • 相关文献

参考文献7

二级参考文献40

  • 1赵建平,周艳萍,白晓红,李风娥,杨国香.泌尿系感染的病原菌分布及耐药性分析[J].中华医院感染学杂志,2004,14(3):350-352. 被引量:77
  • 2张波,府伟灵,张晓兵,廖杨.尿路感染患者的病原菌分布及其耐药性[J].中华医院感染学杂志,2006,16(11):1291-1293. 被引量:57
  • 3朱宁.老年人尿路感染的临床特点及诊治要点[J].中华老年医学杂志,2006,25(12):946-948. 被引量:34
  • 4BONNET R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes[J]. Antimicrob Agents Chcmother,2004,48:1-14.
  • 5National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing[S].Ninth Informatioal Supplement.NCCLS document M 100-S9.
  • 6CDC.Update: Staphylococcus aureus with reduced susceptibility to vancomycin-United States 1997[J].MMWR, 1997, 46: 813-815.
  • 7Murray BE.Vancomycin-resistant enterococci[J].Am J Med, 1997, 102: 284.
  • 8SorbergM,Farra A,Ransion A,et al. Long-term antibiotic resist-ance surveilence of Gramnegtive pathogens suggests that temporaltrends can be used as a resistance warning system[J] , Scand J In-fect Dis,2002,34(5):372.
  • 9FOXMAN B. Epidemiology of urinm'y tract infections :incidence, morbidity, and economic costs[J]. Am J Med,2002,113(Suppl 1A) :5S-13S.
  • 10BOOTH J L, MULLEN A B, THOMSON D A, et al. Antibiotic treatment of urinary tract infection by community pharmacists : a cross-sectional study[J]. Br J Gen Pract,2013,63(609) :244-249.

共引文献98

同被引文献42

  • 1Booth JL, Mullen AB ,Thomson DA, et al. Antibiotic treat- ment of urinary tract infection by community pharmacists: a cross-sectional study [J]. Br J Gen Pract,2013,63(609) : e244-e249.
  • 2Takhar SS,Moran GJ.Diagnosis and management of urinary tract infection in the emergency department and outpatient settings[J].Infectious disease clinics of North America,2014,28(1):33-48.
  • 3Blach O,Rai B,Oates K.et al.An outbreak of schistosomiasis in travellers returning from endemic areas:the importance of rigorous tracing in peer groups exposed to risk of infection[J].J Public Health(Oxf),2012,34(1):32-36.
  • 4Foxman B.The epidemiology of urinary tract infection[J].Nat Rev Urol,2010,7(12):653-660.
  • 5Sarti M,Campanile F,Sabia C,et al.Polyclonal diffusion of betalactamase-producing Enterococcus faecium[J].J Clin Microbiol,2012,50(1):169-172.
  • 6Galipothu S,Kalawat U,Ram R,et al.Cutaneous fungal infection in a renal transplantation patient due to a rare fungus belonging to order Pleosporales[J].Indian J Med Microbiol,2015,33(1):165-167.
  • 7Ipekci T, Seyman D, Berk H, et al. Clinical and bacterio- logical efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase- producing Escherichia eoli or Klebsiella pneumonia [ J 1. J Infect Chemother, 2014, 20( 12): 762-767.
  • 8Duncan C J, Ban" DA, Seaton RA. Outpatient Parenteral An- timicrobial Therapy with Ceftriaxone, a review [ J ]. Int Journal Clin Pharm, 2012, 34(3) : 410-417.
  • 9Poston SA, Jennings HR, Poe KL. Cefazolin Tolerance Does Not Predict Ceftriaxone Hypersensitivity: Unique Side Chains Precipitate Anaphylaxis [ J ]. Phanna~otherapy, 2004, 24(5): 668-672.
  • 10Foxman B. The Epidemiology of Urinary Tract Infection [J]. Nat Rev Urol, 2010, 7(12): 653-660.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部